Irsogladine

Modify Date: 2024-01-02 20:25:30

Irsogladine Structure
Irsogladine structure
Common Name Irsogladine
CAS Number 57381-26-7 Molecular Weight 256.091
Density 1.6±0.1 g/cm3 Boiling Point 552.2±60.0 °C at 760 mmHg
Molecular Formula C9H7Cl2N5 Melting Point 268-269°C
MSDS N/A Flash Point 287.8±32.9 °C

 Use of Irsogladine


Irsogladine is a PDE4 inhibitor and muscarinic acetylcholine receptor binder.Target: PDE4; mACHRIrsogladine treatment (300 and 500 mg/kg/day) resulted in a dose-dependent reduction of angiogenesis in wild-type mice by 21 and 45.3% (P < 0.02, P < 0.001), in tPA-deficient mice by 42.6 and 46% (P < 0.001, P < 0.001), and in uPA-deficient mice by 27.2 and 46% (P < 0.05, p < 0.001), respectively. Irsogladine inhibits bFGF-induced angiogenesis in wild-type, tPA-knockout, and uPA-knockout mice [1]. Irsogladine up-regulates GJIC between PC cells via regulation of the PKA pathway. It also suggests a useful adjuvant of Irsogladine to pancreatic cancer therapy [2]. irsogladine produces the increase of intracellular cAMP content via non-selective inhibition of PDE isozymes, which may be a key mechanism involved in its gastroprotective actions [3].

 Names

Name Irsogladine
Synonym More Synonyms

 Irsogladine Biological Activity

Description Irsogladine is a PDE4 inhibitor and muscarinic acetylcholine receptor binder.Target: PDE4; mACHRIrsogladine treatment (300 and 500 mg/kg/day) resulted in a dose-dependent reduction of angiogenesis in wild-type mice by 21 and 45.3% (P < 0.02, P < 0.001), in tPA-deficient mice by 42.6 and 46% (P < 0.001, P < 0.001), and in uPA-deficient mice by 27.2 and 46% (P < 0.05, p < 0.001), respectively. Irsogladine inhibits bFGF-induced angiogenesis in wild-type, tPA-knockout, and uPA-knockout mice [1]. Irsogladine up-regulates GJIC between PC cells via regulation of the PKA pathway. It also suggests a useful adjuvant of Irsogladine to pancreatic cancer therapy [2]. irsogladine produces the increase of intracellular cAMP content via non-selective inhibition of PDE isozymes, which may be a key mechanism involved in its gastroprotective actions [3].
Related Catalog
References

[1]. Ren, C.J., et al., Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice. J Surg Res, 1998. 77(2): p. 126-31.

[2]. Kawasaki, Y., et al., Irsogladine malate up-regulates gap junctional intercellular communication between pancreatic cancer cells via PKA pathway. Pancreas, 2002. 25(4): p. 373-7.

[3]. Kyoi, T., et al., Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis. Life Sci, 2004. 75(15): p. 1833-42.

 Chemical & Physical Properties

Density 1.6±0.1 g/cm3
Boiling Point 552.2±60.0 °C at 760 mmHg
Melting Point 268-269°C
Molecular Formula C9H7Cl2N5
Molecular Weight 256.091
Flash Point 287.8±32.9 °C
Exact Mass 255.007858
PSA 90.71000
LogP 2.08
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.706
Storage condition -20°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XY5850732
CHEMICAL NAME :
1,3,5-Triazine-2,4-diamine, 6-(2,5-dichlorophenyl)-
CAS REGISTRY NUMBER :
57381-26-7
LAST UPDATED :
199712
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C9-H7-Cl2-N5
MOLECULAR WEIGHT :
256.11

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1740 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4657907

 Safety Information

Hazard Codes Xn,N
Risk Phrases R20:Harmful by inhalation. R51/53:Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment .
Safety Phrases S24-S61
RIDADR UN 2618 3/PG 3
WGK Germany 2
RTECS WL5075900
Packaging Group III
Hazard Class 3
HS Code 2942000000

 Customs

HS Code 2942000000

 Synonyms

2',5'-Dichlorobenzoguanamine
1,3,5-Triazine-2,4-diamine, 6-(2,5-dichlorophenyl)-
MFCD00866871
Irsogladin
6-(2,5-Dichlorophenyl)-1,3,5-triazine-2,4-diamine
gaslon
Irsogladine
Dicloguamine